Clinical trial
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal…
NCT00005864 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005864 |
|---|---|
| Title | Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer |
| Official title | A Phase II Study of Chloroquinoxaline Sulfonamide (CQS) in Colorectal Cancer Stage IV |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | chloroquinoxaline sulfonamide |
| Start date | Apr 1, 2000 |
| Completion | Feb 1, 2004 |
| First posted | Feb 25, 2004 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: